Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions

Dipeptidyl peptidase-4 (DPP-4) inhibitors are reported to exhibit promising effects on several pathological processes associated with Parkinson’s disease (PD). To explore its repositioning potential as an antiparkinsonian agent, we evaluated the effects of omarigliptin (OMG), a DPP-4 inhibitor recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, Noha A., Cho, Jungsook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598347/
https://www.ncbi.nlm.nih.gov/pubmed/36290663
http://dx.doi.org/10.3390/antiox11101940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598347/
https://www.ncbi.nlm.nih.gov/pubmed/36290663
http://dx.doi.org/10.3390/antiox11101940

Ejemplares similares